Intel lands huge Apple chip deal — ride the momentum on Intel
President Trump announced that Intel will work with Apple to design and produce semiconductors inside the United States, causing Intel's stock to surge over 9% in pre-market trading.
Idea
Landing a partnership with Apple is a massive validation of Intel's turnaround strategy to become a major domestic chip manufacturer. This deal provides a guaranteed revenue stream from the world's most valuable tech company and signals to the market that Intel is once again a serious player. As the stock builds positive momentum, traders are likely to keep buying the shares in anticipation of further domestic production announcements. Riding this wave of positive news could push the stock price even higher as institutional investors adjust their positions.
Advanced Analysis — institutional-depth research report
Verdict: compelling story, broken chart — wait for the setup
This is a thesis with a compelling narrative — Intel's 36.1% revenue growth and a genuine Apple partnership per the Bloomberg report — but the live price structure directly contradicts the momentum setup the idea describes. Intel's RSI sits at 20.1 with the 9-period EMA trailing the 21-period by 2.62 points, and the stock trades 35% below its range high; the entry conditions are nowhere near firing. On the fundamental side, a negative 4.2% operating margin and $4.9B in trailing free cash flow burn underscore that this is a narrative bet on forward foundry execution, not an earnings-power story today. The strategy's momentum rules could not be backtested because the 1-hour data lacked sufficient continuous history to form an evaluable window, so no robust parameter setup was established and the decision rests entirely on design logic and live structure. The 0.04 correlation between AAPL and INTC over the 1,028-day lookback offers real diversification, but Intel's 42.2% historical drawdown and 51.0% annualized volatility mean the basket still faces an expected peak-to-trough decline near 42%. Until Intel reclaims the 92.00 support and its EMAs flip bullish, the setup is a wait, not a trade. **Conviction Breakdown** - **Thesis support (40):** The Apple deal is a meaningful catalyst, but Intel's operating losses and free cash flow burn leave the narrative without current earnings confirmation. - **Trade readiness (18):** Every momentum entry condition is unmet — EMAs are bearish, RSI is deeply oversold at 20.1, and price sits below nearest support. - **Risk quality (35):** Intel's 51.0% annualized volatility and 42.2% max drawdown make for a poor risk profile even within a diversified basket. - **Fundamentals trend (52):** Revenue growth of 36.1% and a recent quarterly gross margin improvement to 39.4% are encouraging, but negative ROE and persistent cash burn cap the score.
Trade now
The strategy calls for a long entry on Intel when its 9-period EMA crosses above its 21-period EMA alongside surging volume. That crossover has not happened. Intel's 9-period EMA currently sits at 95.82, roughly 2.62 points below its 21-period EMA at 98.44 — the exact opposite of the entry condition. The stock last closed at 92.32, down sharply from its 50-period simple moving average of 99.60 and well beneath its 200-period average of 116.35. Price is also trading below the nearest support at 92.00, meaning the setup requires the low to touch or pierce that level (currently satisfied) but also needs the close to hold above it, which it does not. On the exit side, the strategy defines a take-profit at nearest resistance (93.00 for Intel) and a protective stop based on the second support tier. With Intel at 92.32, the take-profit target sits less than 1% above current price, offering minimal room for a momentum trade to develop. The 5% stop-loss from the thesis would place invalidation near 87.70, though the strategy's support-based stop logic points to 91.50 (Support Rank 2), which the price has already breached to the downside. Apple, the secondary trade symbol, shows a healthier structure with its 9-period EMA at 330.19 already above its 21-period EMA at 327.83, but the volume confirmation (OBV above 150) cannot be evaluated because On-Balance Volume is not reporting a live value. Because this strategy was not backtestable — the 1-hour data history for both Intel and Apple was too shallow to produce an evaluable window — no validated return, drawdown, or win-rate statistics exist. No robust parameter setup was established either. That means the decision rests entirely on live market structure and the idea's fundamental thesis rather than historical performance data. Waiting concretely means Intel needs to close the 2.62-point gap between its 9- and 21-period EMAs and flip them bullish, hold a close above 92.00 support, and produce a volume reading that exceeds 150 OBV. Until those conditions converge, there is no entry to take.
The Apple deal as a structural turning point
The thesis centers on Apple's chip deal as a transformative validation of Intel's domestic manufacturing turnaround. The fundamentals lend it real support.…
Scores
- Conviction score breakdown: 36
- Thesis support: 40
- Trade readiness: 18
- Risk quality: 35
- Fundamentals trend: 52
Watch items
- INTC — EMA (9) vs EMA (21)
- INTC — Close vs Support Rank 1
- INTC — OBV
- INTC — RSI (14)
- INTC — Close vs Support Rank 2
- AAPL — EMA (9) vs EMA (21)
- AAPL — EMA (9) crossed above EMA (21)
- AAPL — EMA (9) crossed below EMA (21)
- INTC — EMA (9) crossed above EMA (21)
- INTC — EMA (9) crossed below EMA (21)